Haemonetics | HAE - Des Atouts





Des Atouts Changement Date
Avanos Medical USD 1.05B 23.6M 2026-03
Baxter International USD 19.85B 209M 2026-03
Becton, Dickinson and Co. USD 50.83B 4.01B 2026-03
Boston Scientific USD 44.35B 678M 2026-03
Cerus USD 221.86M 6.67M 2025-12
Cooper Companies USD 12.48B 58.1M 2026-03
Fresenius EUR 41.4B 1.07B 2025-12
Fresenius Medical Care EUR 31.47B 465.26M 2026-03
Globus Medical USD 5.44B 136.79M 2026-03
Haemonetics USD 2.4B 94.96M 2026-03
ICU Medical USD 4.01B 36.74M 2026-03
Intuitive Surgical USD 20.88B 765.6M 2026-06
Medtronic USD 91.48B 139M 2025-12
Merit Medical Systems USD 2.72B 33.36M 2026-03
Neogen USD 3.36B 953K 2025-12
OraSure Technologies USD 379.17M 24M 2026-03
Plus Therapeutics USD 19.92M 3.59M 2026-03
Quidel USD 5.63B 140.6M 2026-03
ResMed USD 8.78B 280.91M 2026-03
STAAR Surgical USD 451.12M 560K 2026-03
Steris USD 10.74B 145.8M 2026-03
Stryker USD 46.29B 1.55B 2026-03
Teleflex USD 6.78B 164.24M 2026-03
Terumo JPY 2.31T 55.3B 2026-03
Thermo Fisher Scientific USD 113.28B 2.94B 2026-03
US Physical Therapy USD 1.24B 38.05M 2026-03
Zimmer Biomet Holdings USD 22.72B 370.1M 2026-03